公司资料
Myomo 股价、新闻与催化剂
- 股票代码:
- MYO
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.61 USD (+3.21%)
收盘价
最后更新: 2026年10月1日
41M USD
市值
股价为何变动
截至 2026年10月1日，MYO 上涨 3.21%，收于 $1.61。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Powered Orthotics Company
Myomo develops wearable robotic orthoses for people with impaired arm and hand function. Its devices are intended to help patients perform daily activities after stroke, nerve injury, and other neuromuscular conditions.
MyoPro Product Family
MyoPro detects weak electrical signals from a user's muscles and translates them into powered movement at the elbow, wrist, or hand. Each orthosis is customized to the patient's anatomy and functional needs.
Neuromuscular Patient Population
The device is used by people with upper-limb weakness resulting from stroke, brachial plexus injury, spinal cord injury, multiple sclerosis, and other conditions. Candidates typically retain enough muscle signal to control the powered brace.
Direct-to-Patient Model
Myomo markets directly to prospective users, conducts remote or in-person screening, and works with clinicians and orthotics professionals to complete evaluation and fitting. Patient advocacy and digital lead generation are important to demand creation.
Reimbursement and Fabrication
Revenue depends on insurance authorization and payment, including Medicare and commercial plans. Centralized fabrication, clinical documentation, and claims support help move qualified patients from evaluation to delivery.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。